Shareholders to Vote on Massive Dilution: 5x Authorized Shares, 1120% Future Equity Financing, and New Warrants

summarizeSummary

INVO Fertility, Inc. is seeking shareholder approval for highly dilutive measures, including a 5x increase in authorized shares and a future equity financing that could dilute existing shareholders by over 1,100%, amidst ongoing financial distress.

check_boxKey Events

• Massive Increase in Authorized Shares

  Shareholders will vote to increase the authorized common stock from 50,000,000 to 250,000,000 shares, providing significant headroom for future equity issuances.

• Approval for Highly Dilutive Future Equity Financing

  The company seeks approval for a potential future equity financing of up to 20,000,000 shares, representing approximately 1,120% of current outstanding common stock, with potential gross proceeds of up to $50,000,000. This is a critical capital raise for a company with a 'going concern' warning.

• Approval for Inducement Warrant Issuance

  Shareholders will vote on the issuance of 1,893,492 shares of common stock upon the exercise of new inducement warrants at an exercise price of $7.95 per share, representing approximately 106% potential dilution to current outstanding shares.

• Significant Increase in Stock Incentive Plan Shares

  The 2019 Stock Incentive Plan is proposed to be amended to increase the shares available for issuance to 1,000,000, equivalent to approximately 56% of current outstanding common stock, further contributing to potential dilution.

auto_awesomeAnalysis

INVO Fertility, Inc. has filed its definitive proxy statement, outlining several proposals for shareholder approval that, if passed, would enable extreme dilution. The company, which recently issued a 'going concern' warning and restated financials, is seeking to increase its authorized common stock five-fold from 50 million to 250 million shares. Critically, shareholders will vote on a proposal to authorize a future equity financing of up to 20 million shares, representing approximately 1,120% of current outstanding common stock, with potential proceeds of up to $50 million. This is a staggering amount relative to the company's current market capitalization of approximately $2.4 million. Additionally, approval is sought for the issuance of nearly 1.9 million shares upon the exercise of inducement warrants (representing over 100% dilution) and an increase of 1 million shares (56% dilution) for its stock incentive plan. These measures are presented as necessary to fund working capital, repay debt, and pursue acquisitions to reach cash flow breakeven, highlighting the company's urgent need for capital at a significant cost to existing shareholders.